Moderna

Busy Start to the Year on Wall Street

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:January 3, 2024

The beginning of the year has been bustling on Wall Street, with an influx of stock upgrades and downgrades. This flurry of street-notes has set the tone for the early…

Moderna Announces Company Reorganization

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:December 12, 2023

Moderna Inc. has recently revealed a strategic reorganization aimed at enhancing focus on two key initiatives: driving sales for its COVID vaccine, Spikevax, and preparing for the anticipated launch of…

Phase 3 Trial for Melanoma Treatment

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:July 31, 2023

Merck & Co. (MRK) and Moderna Inc. (MRNA) have announced the initiation of a Phase 3 trial to evaluate the efficacy of Moderna's V940 in combination with Merck's Keytruda as…